We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transfusable Blood to Be Made From ESCs

By LabMedica International staff writers
Posted on 07 Apr 2009
Scientists are attempting to create synthetic blood from embryonic stem cells (ESCs).

Surplus embryos used for in vitro fertilization (IVF) treatments will be screened to find the stem cells that can develop into O-negative blood, which can be transfused into virtually every patient. More...
The stem cells can then be developed into red blood cells, offering potentially an inexhaustible supply of blood for emergency situations. This will be of great significance for the military and emergency units around the world.

In the year 2008 Advanced Cell Technology (Los Angeles, CA, USA) announced that it could make a fresh supply of blood from embryonic stem cells. Scientists in the United Kingdom, Sweden, France, and Australia are also working in the field. A consortium consisting of the NHS Blood and Transplant (Bristol, UK), Scottish National Blood Transfusion Service (Edinburgh, UK), and Wellcome Trust (London, UK) is supporting the project. They believe that the new blood supply should be ready for testing in humans within three years.

Related Links:

Advanced Cell Technology
NHS Blood and Transplant
Scottish National Blood Transfusion Service
Wellcome Trust




New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Electrolyte Analyzer
BKE-B
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.